Yichao Lu

2.5k total citations · 2 hit papers
48 papers, 1.7k citations indexed

About

Yichao Lu is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Yichao Lu has authored 48 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 18 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Yichao Lu's work include Immunotherapy and Immune Responses (16 papers), Nanoplatforms for cancer theranostics (8 papers) and CAR-T cell therapy research (8 papers). Yichao Lu is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), Nanoplatforms for cancer theranostics (8 papers) and CAR-T cell therapy research (8 papers). Yichao Lu collaborates with scholars based in China, Netherlands and Belgium. Yichao Lu's co-authors include Jian You, Yingying Shi, Lihua Luo, Qiang Wu, Mengshi Jiang, Daniele Canzio, Bing Ren, David U. Gorkin, Yonghu Wu and Jinhuan Li and has published in prestigious journals such as Cell, Advanced Materials and Nature Communications.

In The Last Decade

Yichao Lu

46 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CRISPR Inversion of CTCF Sites Alters Genome Topology and Enhancer/Promoter Function

2015 648 citations Ya Guo, Quan Xu et al. Cell profile →
Neutrophil hitchhiking for drug delivery to the bone marrow

2023 118 citations Zhenyu Luo, Yichao Lu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yichao Lu China	20	1.1k	310	225	216	190	48	1.7k
Yingmiao Liu United States	24	1.4k 1.3×	396 1.3×	218 1.0×	192 0.9×	75 0.4×	62	2.2k
Remco van Horssen Netherlands	16	678 0.6×	300 1.0×	216 1.0×	257 1.2×	79 0.4×	20	1.6k
Britta Mueller United States	12	1.1k 1.0×	402 1.3×	208 0.9×	138 0.6×	69 0.4×	14	1.9k
Junlong Zhao China	23	948 0.9×	650 2.1×	116 0.5×	347 1.6×	265 1.4×	45	1.9k
Jingjing Yu China	22	787 0.7×	273 0.9×	287 1.3×	421 1.9×	94 0.5×	82	1.6k
Hong Yao China	25	1.1k 1.0×	229 0.7×	152 0.7×	466 2.2×	37 0.2×	88	1.8k
Marco B.E. Schaaf Netherlands	16	847 0.8×	395 1.3×	183 0.8×	358 1.7×	47 0.2×	19	1.9k
Feng Yan China	17	723 0.7×	228 0.7×	124 0.6×	172 0.8×	65 0.3×	47	1.2k
Mei Zhao China	26	1.1k 1.0×	151 0.5×	106 0.5×	595 2.8×	85 0.4×	62	1.7k
Marie‐Luce Vignais France	24	1.7k 1.6×	246 0.8×	116 0.5×	279 1.3×	112 0.6×	36	2.2k

Countries citing papers authored by Yichao Lu

Since Specialization

Citations

This map shows the geographic impact of Yichao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yichao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yichao Lu more than expected).

Fields of papers citing papers by Yichao Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yichao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yichao Lu. The network helps show where Yichao Lu may publish in the future.

Co-authorship network of co-authors of Yichao Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yichao Lu. A scholar is included among the top collaborators of Yichao Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yichao Lu. Yichao Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Xu, Jiaxin Huang, Huan‐Li Zhou, et al.. (2025). Inhibition of PDT-induced PGE2 surge for enhanced photo-immunotherapy. Biomaterials. 317. 123116–123116. 4 indexed citations

Lu, Yichao, et al.. (2024). Nanoplatform-enhanced photodynamic therapy for the induction of immunogenic cell death. Journal of Controlled Release. 365. 1058–1073. 38 indexed citations

Guo, Xuemeng, Xiang Li, Sijie Wang, et al.. (2024). Optimizing Adoptive Cell Therapy for Solid Tumors via Epigenetic Regulation of T‐cell Destiny. Advanced Healthcare Materials. 13(32). e2402209–e2402209. 2 indexed citations

Wang, Sijie, Junlei Zhang, Huihui Liu, et al.. (2023). The effect of blood velocity in solid tumor on intratumorally accumulation and penetration of nanocarriers and drugs. Nano Today. 50. 101870–101870. 4 indexed citations

Guo, Xuemeng, Junlei Zhang, Yichao Lu, et al.. (2023). Antioxidant nanoemulsion loaded with latanoprost enables highly effective glaucoma treatment. Journal of Controlled Release. 361. 534–546. 14 indexed citations

Lu, Yichao & Jian You. (2023). Strategy and application of manipulating DCs chemotaxis in disease treatment and vaccine design. Biomedicine & Pharmacotherapy. 161. 114457–114457. 4 indexed citations

Luo, Zhenyu, Lihua Luo, Yichao Lu, et al.. (2022). Dual-binding nanoparticles improve the killing effect of T cells on solid tumor. Journal of Nanobiotechnology. 20(1). 261–261. 12 indexed citations

Shi, Yingying, Yu Liu, Jiaxin Huang, et al.. (2022). Optimized mobilization of MHC class I- and II- restricted immunity by dendritic cell vaccine potentiates cancer therapy. Theranostics. 12(7). 3488–3502. 17 indexed citations

Yin, Lingdi, Yichao Lu, Cheng Cao, et al.. (2022). CA9-Related Acidic Microenvironment Mediates CD8+ T Cell Related Immunosuppression in Pancreatic Cancer. Frontiers in Oncology. 11. 832315–832315. 23 indexed citations

10.

Meng, Lingdong, Yihan Zhang, Pengfei Wu, et al.. (2022). CircSTX6 promotes pancreatic ductal adenocarcinoma progression by sponging miR-449b-5p and interacting with CUL2. Molecular Cancer. 21(1). 121–121. 54 indexed citations

11.

Qin, Bing, Mengshi Jiang, Xiang Li, et al.. (2021). Oxygen nanocarrier broke the hypoxia trap of solid tumors and rescued transfection efficiency for gene therapy. Journal of Nanobiotechnology. 19(1). 427–427. 9 indexed citations

12.

Li, Xiang, Lihua Luo, Mengshi Jiang, et al.. (2021). Cocktail strategy for ‘cold’ tumors therapy via active recruitment of CD8+ T cells and enhancing their function. Journal of Controlled Release. 334. 413–426. 27 indexed citations

13.

Shi, Yingying, Yichao Lu, & Jian You. (2021). Unfolded protein response in the activation-induced biological processes of CD8+ T cells. Pharmacological Research. 169. 105654–105654. 5 indexed citations

14.

Lu, Yichao, Yingying Shi, & Jian You. (2021). Strategy and clinical application of up-regulating cross presentation by DCs in anti-tumor therapy. Journal of Controlled Release. 341. 184–205. 27 indexed citations

15.

Shi, Yingying, Yichao Lu, Chunqi Zhu, et al.. (2021). Targeted regulation of lymphocytic ER stress response with an overall immunosuppression to alleviate allograft rejection. Biomaterials. 272. 120757–120757. 13 indexed citations

16.

Zhu, Chunqi, Yingying Shi, Qingpo Li, et al.. (2021). Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect. Journal of Controlled Release. 341. 769–781. 16 indexed citations

17.

Ge, Wanli, Qun Chen, Lingdong Meng, et al.. (2020). The YY1/miR-548t-5p/CXCL11 signaling axis regulates cell proliferation and metastasis in human pancreatic cancer. Cell Death and Disease. 11(4). 294–294. 20 indexed citations

18.

Meng, Lingdong, Guodong Shi, Wanli Ge, et al.. (2020). Linc01232 promotes the metastasis of pancreatic cancer by suppressing the ubiquitin-mediated degradation of HNRNPA2B1 and activating the A-Raf-induced MAPK/ERK signaling pathway. Cancer Letters. 494. 107–120. 59 indexed citations

19.

Lu, Yichao, Ping Lyu, Haifeng Zhang, et al.. (2017). Brachial–ankle pulse wave velocity compared with mean arterial pressure and pulse pressure in risk stratification in a Chinese population. Journal of Hypertension. 36(3). 528–536. 20 indexed citations

20.

Guo, Ya, Quan Xu, Daniele Canzio, et al.. (2015). CRISPR Inversion of CTCF Sites Alters Genome Topology and Enhancer/Promoter Function. Cell. 162(4). 900–910. 648 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact